Meribel Pharma Solutions launches to take pharma services to new heights
April 22, 2025Manufacturing Services, Manufacturing and Production CMDO, Corporate, Meribel Pharma Solutions, manufacturing
Meribel Pharma Solutions, a new mid-sized contract development and manufacturing organisation (CDMO), has officially launched with operations across 13 sites …
Allegro confirms successful safety testing of osteoarthritis treatment
April 17, 2025Research and Development Allegro, Osteoporosis, joint disease, oesteoarthritis, pretrial
Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment …
Johnson & Johnson announces successful results from trial for myeloma treatment
April 16, 2025Research and Development Johnson & Johnson, Oncology, myeloma, pharma, trial
Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) …
Astraveus expands leadership team ahead of Lakhesys launch
April 16, 2025Manufacturing Services Astraveus, Corporate, appointment
Astraveus has announced a series of senior appointments as it advances towards the launch of its Lakhesys Benchtop Cell Factory, …
Moderna authorised to upscale development of mRNA vaccines in UK
April 15, 2025Manufacturing and Production Moderna, UK, UK government, Virology, mrna, vaccination
Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …
ProQR appoints new CFO and CMO to drive clinical-stage growth
April 15, 2025Research and Development Corporate, ProQR, appointments, clinical development
ProQR Therapeutics announced two major leadership appointments to support its transition into the clinical development phase of its RNA editing …
Survey suggests Britons with a disability are concerned over AI-integrated healthcare
April 14, 2025Business Services, Consultancy, Medical Communications AI, Consultancy, Corporate, Pharmacy, nuom, survey
A survey conducted by nuom, a British healthcare consultancy, found a majority of UK adults with a disability are concerned …
Successful trial results announced for potential rare eye disease treatment
April 14, 2025Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease
Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …
Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch
April 14, 2025Market Access, Research and Development, Sales and Marketing Nordic Pharma, Opthalmology, dry eye disease
International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) …
First cohort dosed with potential treatment for Von Willebrand disease
April 11, 2025Research and Development Haematology, Hemab Therapeutics, Richmond Pharma, Von Willebrand Disease, bleeding disorder
UK-based clinical trials company, Richmond Pharmacology, has completed the first stage of Velora Pioneer, a phase 1/2 clinical trial investigating …
Inbiome’s rapid diagnostic platform approved for EU use, cuts infection identification time to just five hours
April 11, 2025Research and Development Diagnostics, EU, Inbiome
Dutch diagnostics firm Inbiome has received In Vitro Diagnostic Regulation (IVDR) certification from the EU for its Molecular Culture ID …
West Middlesex Hospital goes live with tech to reduce prescribing errors
April 10, 2025Information Technology, Manufacturing and Production Dosium, NHS, Paediatrics, West Middlesex Hospital
Dosium Touchdose has gone live at West Middlesex University Hospital, UK, a clinical decision support technology proven to significantly reduce …
AAX Biotech aims to enhance growth with two new appointments
April 10, 2025Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development
AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …
Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
April 10, 2025Research and Development Alzheimer's disease, Neurology, TauRx Pharmaceutics, research and development
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over …
Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer
April 9, 2025Research and Development Infinitopes, Oncology, biotech, oesophageal cancer, oncology
The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …
Ipsen’s Iqirvo approved for use in NHS Scotland to treat rare liver disease
April 8, 2025Research and Development R&D, Rare Diseases, Scottish Medicines Consortium, ipsen, primary biliary cholangitis (PBC)
The Scottish Medicines Consortium (SMC) has accepted the use of Ipsen’s Iqirvo (elafibranor) in NHS Scotland for the treatment of …
High Force Research appoints Nathalie Huther as chief commercial officer
April 8, 2025Manufacturing and Production, Research and Development Corporate, High Force Research, cco, manufacturing and production
High Force Research has announced that it has appointed Nathalie Huther as its first chief commercial officer (CCO) following the …
ELRIG appoints Del Trezise as chair
April 8, 2025Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma
ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …
Academy of Medical Sciences invests record £7.6m into early-career biomedical researchers
April 7, 2025Research and Development Academy of Medical Sciences, British Heart Foundation, Corporate, Wellcome, biomedical research, funding
The Academy of Medical Sciences has awarded £7.6m to support 62 early-career biomedical researchers across the UK, marking the largest …
European consortium launches project to advance alpha-emitting radiotherapies
April 7, 2025Research and Development Akiram Therapeutics, European Consortium, Oncology, PreTT, TetraKit Technologies, radiotherapy
A new European research initiative PRE-CISE has been launched with the aim of developing next-generation targeted alpha-therapies for cancer treatment. …
Latest content
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner
